Login
$VRTX
$543.99 +$5.39 (1.0%) Live

$VRTX 8-K/A SEC Filings

Filed On Filing
27 Oct 2017 8-K/A: Completion of Acquisition or Disposition of Assets

On October 23, 2017, Vertex Pharmaceuticals Incorporated (“Vertex” or the “Company”) concluded that the intangible asset related to Parion Sciences, Inc.'s (“Parion”) pulmonary ENaC platform had become fully impaired based on data from a...

09 Jan 2017 8-K/A: Results of Operations and Financial Condition

-Full-year 2016 product revenues of approximately $703 million for KALYDECO and $979 million for ORKAMBI; total 2016 CF product revenues of $1.68 billion compared to $983 million in 2015-

31 Jan 2014 8-K/A: Completion of Acquisition or Disposition of Assets

On January 27, 2014, Vertex Pharmaceuticals Incorporated (“Vertex,” the “Company” or “we”) concluded that the intangible asset related to the HCV nucleotide analogue program (VX-135) had become fully impaired. This conclusion was based o...

11 May 2009 8-K/A: Completion of Acquisition or Disposition of Assets

We have audited the balance sheets of ViroChem Pharma Inc. as at December 31, 2008 and 2007 and the statements of loss, deficit and cash flows for the years then ended. These financial statements are the responsibility of the Company’s m...

13 Feb 2006 8-K/A: Results of Operations and Financial Condition; Other Events

Cambridge, MA, February 7, 2006 — Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the quarter and year ended December 31, 2005. The Company also provided its full year 2006 financial g...

10 Sep 2004 8-K/A: Other Events

QuickLinks -- Click here to rapidly navigate through this document

10 Sep 2004 8-K/A: Other Events

QuickLinks -- Click here to rapidly navigate through this document

28 Sep 2001 8-K/A: Completion of Acquisition or Disposition of Assets

On July 18, 2001, Vertex Pharmaceuticals Incorporated (Vertex) completed a merger with Aurora Biosciences Corporation (Aurora). Vertex acquired all of Aurora's outstanding common stock in a tax-free, stock for stock transaction, for appr...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support